Sigba, Bb Boy .
HRN: 22-01-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/07/2023
CEFUROXIME 750MG (VIAL)
03/07/2023
03/14/2023
IV
165mg
Q8hours
AGE With Moderate Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes